glp-1 problems Dry Mouth, Bad Breath, & Taste Changes: What Actually Helps? GLP-1 Medications May Activate Visceral

It is used primarily for managing type 2 diabetes and supporting weight loss

Postgrad Med (2019) 131(2):828

In April 2026, the FDA published a formal proposal in the Federal Register to remove semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list, with a public comment period open through June 2026

dehydration makes nausea worse and raises kidney injury risk

Access this article Similar content being viewed by others Data availability Data sharing not applicable to this article as no datasets were generated or analyzed during the current study

Introduction Overeating on semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) can feel very different from what you are used to